Professional
Added to YB: 2025-12-01
Pitch date: 2025-10-31
AZN [neutral]
AstraZeneca PLC
+16.42%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
Market Cap
GBP 299.4B
Pitch Price
GBP 124.17
Price Target
N/A
Dividend
1.63%
EV/EBITDA
15.96
P/E
29.07
EV/Sales
5.39
Sector
Pharmaceuticals
Category
special_situation
Show full summary:
Liontrust Special Situations Fund Portfolio Holding: AstraZeneca PLC
AZN (holding update): Shares up on Trump pricing deal lowering consumer costs for select medicines in exchange for tariff relief, following Pfizer's similar agreement. Reiterated 2025 guidance of low double-digit core EPS growth. Sector optimism for more pricing deals.
Read full article (1 min)